Ms. Orikeda Trashi, University of Texas at Dallas, United States
Ms. Orikeda Trashi is a fourth-year doctoral student at the University of Texas at Dallas, United States, in the Department of Chemistry and Biochemistry. Her research focuses on innovative approaches to cancer therapy, specifically exploring slow-release mechanisms and nanocarriers. With a strong foundation in chemistry and a passion for advancing healthcare through nanotechnology, she is dedicated to contributing to breakthroughs in cancer treatment.
Education
Doctoral Program
Institution: University of Texas at Dallas, Chemistry and Biochemistry Department, United States
Duration: 2021–Present
Program: Doctoral studies focused on Chemistry
Master of Science in Chemistry
Institution: Adam Mickiewicz University, Chemistry Department, Poland
Duration: 2019–2021
Program: MSc in Chemistry
Bachelor of Science in Chemistry
Institution: University of Tirana, Chemistry Department, Albania
Duration: 2015–2018
Program: BSc in Chemistry
Professional Profiles
ORCID Profile
Scopus Profile
Professional Experience
Ms. Orikeda Trashi is currently a Teaching Assistant at the University of Texas at Dallas, United States, where she has demonstrated her expertise and passion for education. Since Spring 2024, she has been involved in teaching the Advanced Organic Synthesis Laboratory, fostering hands-on learning for students. Previously, from Spring 2023 to Fall 2023, she served as a Lecture Teaching Assistant in Organic Synthesis, effectively supporting course delivery and ensuring students’ comprehension of complex organic synthesis concepts. From Fall 2021 to Spring 2022, she contributed to the Organic Chemistry Laboratory I and II courses, guiding students through foundational and advanced laboratory techniques.
In addition to her academic contributions, Ms. Trashi is an accomplished entrepreneur. Since 2015, she has been the driving force behind FOXY BEAUTY, an online platform offering beauty products and services, showcasing her business acumen and creativity. Furthermore, she co-founded BLENDSHAKE in 2021, a venture aimed at delivering innovative and health-conscious beverage solutions. These entrepreneurial endeavors highlight her ability to combine scientific knowledge with business strategy, creating impactful and innovative ventures.
Research Experience
Ms. Orikeda Trashi, affiliated with the University of Texas at Dallas in the United States, has accumulated extensive research experience in her academic journey. Her work primarily focuses on [insert specific research field or area if known], where she has demonstrated exceptional analytical and problem-solving skills. Ms. Trashi has been actively involved in designing and conducting experiments, analyzing complex datasets, and contributing to the advancement of knowledge through innovative solutions and methodologies. She has collaborated with interdisciplinary teams, leveraging her expertise to address critical challenges and achieve impactful results. Her dedication to research excellence is reflected in her publications, conference presentations, and contributions to high-impact projects, showcasing her commitment to academic and scientific innovation.
Research Interests
Ms. Orikeda Trashi esearch focuses on innovative approaches to cancer therapy, specifically exploring slow-release mechanisms and nanocarriers.
Awards and Honours
Best Organization Award
Institution: University of Texas at Dallas (UT Dallas)
Event: UT Dallas Qualification Exam 1, Oral Presentation
Date: May 2022
2nd Place Award
Event: ACS DFW MiM 2024, Oral Presentation
Date: April 2024
Mei Lein Fellowship
Date: August 2024
Contributions to the Scientific Community:
Albanians in Science
Role: Contributor
Duration: October 2021 – February 2023
Judge
Event: Plano ISD Science & Engineering Fair
Date: January 2024
Top Notable Publications
“How Should Journals Address a Procedure That Turns out to Be Dangerous?”
Authors: Trashi, O.; Satish, N.; Nguyen, T.-Q.N.; Gassensmith, J.J.; Mulcahy, M.B.
Year: 2024
Citations: 0
“A scalable synthesis of adjuvanting antigen depots based on metal-organic frameworks”
Authors: Ehrman, R.N.; Brohlin, O.R.; Wijesundara, Y.H.; Smaldone, R.A.; Gassensmith, J.J.
Year: 2024
Citations: 6
“Mn and Zn-Doped Multivariate Metal–Organic Framework as a Metalloimmunological Adjuvant to Promote Protection Against Tuberculosis Infection”
Authors: Howlett, T.S.; Kumari, S.; Ehrman, R.N.; Izzo, A.A.; Gassensmith, J.J.
Year: 2024
Citations: 0
“In vivo biocompatibility of ZIF-8 for slow release via intranasal administration”
Authors: Kumari, S.; Howlett, T.S.; Ehrman, R.N.; Wijesundara, Y.H.; Gassensmith, J.J.
Year: 2023
Citations: 17
“Self-assembly of a fluorescent virus-like particle for imaging in tissues with high autofluorescence”
Authors: Trashi, I.; Durbacz, M.Z.; Trashi, O.; Nielsen, S.O.; Gassensmith, J.J.
Year: 2023
Citations: 3
“Enhanced Nanobubble Formation: Gold Nanoparticle Conjugation to Qß Virus-like Particles”
Authors: Parsamian, P.; Liu, Y.; Xie, C.; Qin, Z.; Gassensmith, J.J.
Year: 2023
Citations: 11
“Rip it, stitch it, click it: A Chemist’s guide to VLP manipulation”
Authors: Wijesundara, Y.H.; Herbert, F.C.; Kumari, S.; Al-Kharji, N.M.; Gassensmith, J.J.
Year: 2022
Citations: 7
“Carrier gas triggered controlled biolistic delivery of DNA and protein therapeutics from metal-organic frameworks”
Authors: Wijesundara, Y.H.; Herbert, F.C.; Trashi, O.; De Nisco, N.J.; Gassensmith, J.J.
Year: 2022
Citations: 17
Conclusion: